On his blog Chief Executive Officer Clay Siegall posted an ESPN article about one of Tom Brady’s family version Super Bowl rings. The ring was owned by one of his family members who put it up for auction. It sold for a record amount for Super Bowl rings, $344.927. The last ring to sell for a record amount was in 2012 when the Lawrence Taylor, formerly an LB for the Giants, sold his for $230,401. The family version of a Super Bowl ring is similar to the one Tom Brady still owns but it has 18 fewer diamonds in it and is 10% smaller.
In other NFL news on his blog, Clay Siegall has another ESPN article about the Tampa Bay Buccaneers running back Peyton Barber. He has dyslexia but he says that he considers his condition as an asset, not a disability. He says that when he tries to read his playbook it often makes little to no sense. To understands the playbook by reading it over and over again as well as drawing them out on paper. What helps the most, though, is that he does a physical walkthrough of each play so that he can fully understand it.
Clay Siegall is the CEO of Seattle Genetics, Inc. He co-founded this company in 1998 and became the CEO in 2001. When their first drug was approved by the FDA, Adcetris, he said that he and his team had basically no experience at all when it came to launching a drug commercially. Because of this he formed a partnership with another firm, Takeda, to successfully launch this cancer drug in the United States and Canada. He says that in return for Takeda paying his company substantial amounts of money they brought his drug to market and handled the marketing.
Over the past 17 years Clay Siegall has formed partnerships with a number of pharmaceutical companies. He says that sometimes he is approached to form a partnership and sometimes he seeks them out. One of the partnerships Clay Siegall signed was with Astellas and he signed a 50/50 partnership with them for their cancer drug Enfortumab vedotin.